Evidence map›Paper›PMID 32206282›Full record

ArticleChemical science2020

Readily accessible sp

Conor Dean, Sundaram Rajkumar, Stefan Roesner, Nessa Carson, Guy J Clarkson, Martin Wills, Matthew Jones, Michael Shipman

Abstract read
In one paragraph

Article in Chemical science, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Control of dynamic spNature chemistry · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Conor DeanDepartment of Chemistry , University of Warwick , Gibbet Hill Road , Coventry , CV4 7AL , UK . Email: m.shipman@warwick.ac.uk.ORCID 0000-0002-1314-245X
Sundaram RajkumarDepartment of Chemistry , University of Warwick , Gibbet Hill Road , Coventry , CV4 7AL , UK . Email: m.shipman@warwick.ac.uk.
Stefan RoesnerDepartment of Chemistry , University of Warwick , Gibbet Hill Road , Coventry , CV4 7AL , UK . Email: m.shipman@warwick.ac.uk.ORCID 0000-0003-2143-4708
Nessa CarsonAMRI UK, Ltd. , Erl Wood Manor , Windlesham , Surrey GU20 6PH , UK.ORCID 0000-0002-2769-1775
Guy J ClarksonDepartment of Chemistry , University of Warwick , Gibbet Hill Road , Coventry , CV4 7AL , UK . Email: m.shipman@warwick.ac.uk.ORCID 0000-0003-3076-3191
Martin WillsDepartment of Chemistry , University of Warwick , Gibbet Hill Road , Coventry , CV4 7AL , UK . Email: m.shipman@warwick.ac.uk.ORCID 0000-0002-1646-2379
Matthew JonesEli Lilly & Company Ltd. , Erl Wood Manor , Windlesham , Surrey GU20 6PH , UK.
Michael ShipmanDepartment of Chemistry , University of Warwick , Gibbet Hill Road , Coventry , CV4 7AL , UK . Email: m.shipman@warwick.ac.uk.ORCID 0000-0002-3349-5594

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Increased molecular complexity correlates with improved chances of success in the drug development process. Here, a strategy for the creation of sp

Identifiers

PMID32206282
PMCPMC7069508

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.